The Food and Drug Administration (FDA) has approved Breztri Aerosphere ® (budesonide/glycopyrrolate/formoterol fumarate; BGF) for the maintenance treatment of asthma in adult and ...

Sleep Apnea Solution author Dylan Petkus, MD, has developed a non-device, behavior-based alternative approach to sleep apnea.

The FDA is moving to speed drug development and review by launching real-time clinical trials, which could mean more options for patients.

The FDA has accepted the NDA for zipalertinib to treat adult patients with locally advanced or metastatic EGFR exon 20 insertion-mutated NSCLC.

Youth cannabis use between ages 9 and 17 years is associated with slower cognitive development during a time of key brain development.

Anxiety and depression are prevalent in patients with IPF and are linked to increased breathlessness and lower energy levels.

In cystic fibrosis, ETI significantly reduced daily cough frequency and increased physical activity levels in patients aged ...

Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...

Race-based medicine continues to negatively impact Black patient populations, advocated Joel Bervell, MD, at RPA 2026.

The updated guideline also strongly recommends RSV vaccination in adults and adolescents with compromised immunity. RSV ...

Oncologists are leveraging TikTok to provide evidence-based cancer education, breaking down complex clinical topics for ...

In-hospital mortality for MV-ARDS improved in the ICD-9-CM era but worsened in the ICD-10-CM era, when a more stringent ARDS definition was used.